USCDI Export for the Public
Classification Level Sort descending | Data Class | Data Class Description | Data Element | Data Element Description | Applicable Standards | Submitter Name | Submitter Organization | Submission Date |
---|---|---|---|---|---|---|---|---|
Level 0 | Genomics | Variant Clinical Significance | Clinical significance is an assessment of the magnitude of a genetic variant's clinical effects as per estimates supplied by researchers and/or guidelines (source: HL7 Clinical Genomics Working Group). |
LOINC is the reference terminology proposed by the HL7 Genomics Reporting FHIR IG (http://hl7.org/fhir/uv/genomics-reporting/index.html) for codifying the ACMG clinical significance categories (https://loinc.org/LL4034-6/) |
May Terry | MITRE Corporation | ||
Level 0 | Clinical Notes | Narrative patient data relevant to the context identified by note types.
|
Physical Exam | Narrative clinical assessment of the Physical Exam results. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
Level 0 | Cancer Care | Provider Reported Toxicity Value | For each Cancer Patient - Provider Reported Toxicity record the Toxicity Value corresponding to the Toxicity Measure specified indicates the severity of the toxicity using the standardized table. specifies what value is measured. For example if CTCAE v5.0 (https://ctep.cancer.gov/protocoldevelopment/electronic_applications/doc…) the values in the standardized set are 0,1,2,3,4,5 The AAPM Operational Ontology for Radiation Oncology ( https://aapmbdsc.azurewebsites.net) identified this as a high priority element supporting patient care, outcomes research and public policy |
Common Terminology Criteria for Adverse Events |
Charles Mayo | University of Michigan | ||
Level 0 | Cancer Care | Provider Reported Toxicity Measure | For each Cancer Patient - Provider Reported Toxicity record the Toxicity Measure specifies what value is measured. For example if CTCAE v5.0 (https://ctep.cancer.gov/protocoldevelopment/electronic_applications/doc…) is used then the Toxicity Measure would correspond to CTCAE Term (e.g. Dry Mouth, or Dry Mouth) The AAPM Operational Ontology for Radiation Oncology ( https://aapmbdsc.azurewebsites.net) identified this as a high priority element supporting patient care, outcomes research and public policy |
Common Terminology Criteria for Adverse Events |
Charles Mayo | University of Michigan | ||
Level 0 | Cancer Care | Radiation Therapy Outcome/Disease Status | Status of the disease treated with radiation therapy at the time of the record. Under Treatment No evidence of disease (NED) Stable Disease Partial Response Progressive Disease Indeterminate (possible pseudo-progression) Complete Response Biochemical Recurrence Primary Recurrence Local Recurrence Nodal Recurrence Distant Recurrence In OORO for each instance record of a Cancer Patient Treatment Outcome, multiple values of Disease Status can be selected e.g. Biochemical Recurrence, Nodal Recurrence |
Charles Mayo | University of Michigan | |||
Level 0 | Outcomes | Outcome | Outcome of the event – i.e. death, hospitalization, fever |
HL7.org FHIR R4 v4.0 |
Sandi Mitchell | J P Systems, Inc. | ||
Level 0 | Clinical Notes | Narrative patient data relevant to the context identified by note types.
|
Psychological Testing | Narrative clinical assessment of the Psychological Testing results. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
Level 0 | Outcomes | Mitigating action | Ameliorating actions taken after the adverse event occurred in order to reduce the extent of harm |
HL7.org FHIR R4 v4.0 |
Sandi Mitchell | J P Systems, Inc. | ||
Level 0 | Medications | Pharmacologic agents used in the diagnosis, cure, mitigation, treatment, or prevention of disease. |
Medication Start/End Date | The start and end date of a medication order. |
Sandi Mitchell | J P Systems, Inc. | ||
Level 0 | Vital Signs | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Total Output | The total volume that the patient put out during a calendar day, from all sources, including urine, stool, and drains like chest tubes, surgical drains, intrathecal catheters, external ventricular drains, peritoneal catheters. | LOINC 9097-7 Fluid balance 24hrs SNOMED CT 251856003 Fluid balance |
Ali Abbas MD | UCSF | |
Level 0 | Clinical Notes | Narrative patient data relevant to the context identified by note types.
|
Neuropsychological Testing | Narrative clinical assessment of the Neuropsychological Testing results. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
Level 0 | Vital Signs | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Urine Output | The total urine output during a calendar day, from all sources including voids, bladder catherization, urostomy, nephrostomy tubes. | LOINC 9097-7 Fluid balance 24hrs SNOMED CT 251856003 Fluid balance |
Ali Abbas MD | UCSF | |
Level 0 | Health Status Assessments | Assessments of a health-related matter of interest, importance, or worry to a patient, patient’s family, or patient’s healthcare provider that could identify a need, problem, or condition. |
Mental Status Evaluation | Narrative clinical assessment of the Mental Status Evaluation. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
Level 0 | Clinical Notes | Narrative patient data relevant to the context identified by note types.
|
Genetic Testing | Narrative clinical assessment of the Genetic Testing results. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
Level 0 | Cancer Care | Secondary Cancer Condition | Also known as secondary malignant neoplasm, secondary cancer condition is used to describe either a new primary cancer or cancer that has spread from the place in which it started to other parts of the body (Source: NCI). |
Three terminologies are commonly referenced for the exchange of secondary/metastatic cancer conditions: |
May Terry | MITRE Corporation | ||
Level 0 | Clinical Tests | Non-imaging and non-laboratory tests performed that result in structured or unstructured findings specific to the patient to facilitate the diagnosis and management of conditions. |
EKG/ECG Tracing Image | Narrative interpretation of the EKG/ECG Tracing Image. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
Level 0 | Clinical Tests | Non-imaging and non-laboratory tests performed that result in structured or unstructured findings specific to the patient to facilitate the diagnosis and management of conditions. |
Myelogram | Narrative clinical assessment of the Myelogram results. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
Level 0 | Clinical Notes | Narrative patient data relevant to the context identified by note types.
|
Colonoscopy | Narrative clinical assessment of the Colonoscopy results. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
Level 0 | Cancer Care | Staging System | A cancer staging system is used to describe the extent of cancer in the body. There are many staging systems. Some, such as the TNM staging system, are used for many types of somatic cancer. Others are specific to a particular type of cancer (Source: NCI). Examples of non-TNM staging systems include the Cotswolds Modifications of the Ann Arbor Staging Classification, Revised International Staging System (R-ISS), and Rai and Binet staging systems for chronic lymphocytic leukemia. |
SNOMED CT specifies codes for describing different cancer staging systems. |
May Terry | MITRE Corporation | ||
Level 0 | Vital Signs | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Individual Administering Vital Signs | Identify the role of the individual taking the vital signs, differentiating between inputs that are from a care team member, patient or family/caregiver, as separate from an automated device or home monitoring system. |
For care team members: Examples include but are not limited to National Provider Identifier (NPI) and National Council of State Boards of Nursing Identifier (NCSBN ID). For FDA approved devices: FDA Unique Device Identification (UDI) System |
Tayler Williams | American Medical Informatics Association (AMIA) |